ATE83649T1 - Arzneimittelzubereitungen mit verzoegerter freisetzung. - Google Patents
Arzneimittelzubereitungen mit verzoegerter freisetzung.Info
- Publication number
- ATE83649T1 ATE83649T1 AT87108670T AT87108670T ATE83649T1 AT E83649 T1 ATE83649 T1 AT E83649T1 AT 87108670 T AT87108670 T AT 87108670T AT 87108670 T AT87108670 T AT 87108670T AT E83649 T1 ATE83649 T1 AT E83649T1
- Authority
- AT
- Austria
- Prior art keywords
- delayed
- release medications
- medications
- release
- processability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B33/00—After-treatment of single crystals or homogeneous polycrystalline material with defined structure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/875,146 US4810501A (en) | 1986-06-17 | 1986-06-17 | Sustained release pharmaceutical preparations |
EP87108670A EP0249949B1 (de) | 1986-06-17 | 1987-06-16 | Arzneimittelzubereitungen mit verzögerter Freisetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE83649T1 true ATE83649T1 (de) | 1993-01-15 |
Family
ID=25365278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87108670T ATE83649T1 (de) | 1986-06-17 | 1987-06-16 | Arzneimittelzubereitungen mit verzoegerter freisetzung. |
Country Status (17)
Country | Link |
---|---|
US (1) | US4810501A (de) |
EP (1) | EP0249949B1 (de) |
JP (1) | JPS63258406A (de) |
KR (1) | KR950003609B1 (de) |
AT (1) | ATE83649T1 (de) |
AU (1) | AU611085B2 (de) |
CA (1) | CA1297016C (de) |
DE (1) | DE3783163T2 (de) |
DK (1) | DK305287A (de) |
ES (1) | ES2053470T3 (de) |
FI (1) | FI872652A (de) |
GR (1) | GR3006981T3 (de) |
NO (1) | NO872499L (de) |
NZ (1) | NZ220722A (de) |
PH (1) | PH24152A (de) |
PT (1) | PT85105B (de) |
ZA (1) | ZA873851B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8707416D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
US5186930A (en) * | 1988-11-14 | 1993-02-16 | Schering Corporation | Sustained release oral suspensions |
US4999189A (en) * | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
GB9025372D0 (en) * | 1990-11-22 | 1991-01-09 | Nat Res Dev | Pharmaceutical dosage forms |
US5683719A (en) * | 1990-11-22 | 1997-11-04 | British Technology Group Limited | Controlled release compositions |
US5358723A (en) * | 1991-11-26 | 1994-10-25 | Warner-Lambert Company | Process and composition for the development of controlled release gemfibrozil dosage form |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5681585A (en) * | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5348747A (en) * | 1992-03-05 | 1994-09-20 | American Home Products Corporation | Pharmaceutical coating sugars |
US5429822A (en) * | 1992-03-13 | 1995-07-04 | Cambridge Scientific, Inc. | Biodegradable bursting release system |
AU5681294A (en) * | 1992-11-30 | 1994-06-22 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
US5456917A (en) * | 1993-04-12 | 1995-10-10 | Cambridge Scientific, Inc. | Method for making a bioerodible material for the sustained release of a medicament and the material made from the method |
FR2723846B1 (fr) * | 1994-08-24 | 1997-06-13 | Hi Pharmtech | Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble |
ES2194100T3 (es) * | 1995-05-09 | 2003-11-16 | Phoqus Ltd | Revestimiento electrostatico. |
US7008668B2 (en) * | 1995-05-09 | 2006-03-07 | Phoqus Pharmaceuticals Limited | Powder coating composition for electrostatic coating of pharmaceutical substrates |
GB9623634D0 (en) * | 1996-11-13 | 1997-01-08 | Bpsi Holdings Inc | Method and apparatus for the coating of substrates for pharmaceutical use |
US6479082B1 (en) | 1996-12-23 | 2002-11-12 | Wm. Wrigley, Jr. Co. | Process of increasing flavor release from chewing gum using hydroxypropyl cellulose and product thereof |
ES2263211T3 (es) | 1997-07-02 | 2006-12-01 | Euro-Celtique S.A. | Formulaciones de tramadol de liberacion sostenida estabilizada. |
EP0943341A1 (de) * | 1998-02-18 | 1999-09-22 | Oscar Gold | Verfahren zur Herstellung von Erythromycin Macrolide enthaltenden Granulaten und Arzneimitteln |
RU2266012C2 (ru) | 1999-04-01 | 2005-12-20 | Вм. Ригли Дж. Компани | Способ получения структуры для обеспечения продленного выделения ароматизатора для жевательной резинки, состав (варианты) и способ получения жевательной резинки, содержащей эту структуру |
GB0002305D0 (en) * | 2000-02-01 | 2000-03-22 | Phoqus Limited | Power material for electrostatic application |
FR2807771A1 (fr) * | 2000-04-12 | 2001-10-19 | Atofina | Procede de modification hydrophile d'un substrat mettant en jeu un traitement en milieu aqueux par un polymere soluble dans l'eau et thermosensible |
WO2003020242A1 (en) * | 2001-08-29 | 2003-03-13 | Srl Technologies, Inc. | Sustained release preparations |
GB2402895B (en) * | 2003-06-18 | 2006-08-23 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
GB0330171D0 (en) * | 2003-12-30 | 2004-02-04 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
GB0407312D0 (en) * | 2004-03-31 | 2004-05-05 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
US8236759B2 (en) * | 2005-06-30 | 2012-08-07 | Ipsen Pharma Sas | GLP-1 pharmaceutical compositions |
WO2007016948A1 (de) | 2005-08-10 | 2007-02-15 | Add Advanced Drug Delivery Technologies Ltd. | Orales präparat mit kontrollierter freisetzung |
KR101402592B1 (ko) * | 2006-03-06 | 2014-06-17 | 에스케이바이오팜 주식회사 | 피록시캄-무기물 복합체를 포함하는 경피투여 조성물 및이를 이용한 패치시스템 |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
US10668963B2 (en) * | 2014-04-16 | 2020-06-02 | Komatsu Ltd. | Idler wheel, crawler-type travel device, and wear plate |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2897121A (en) * | 1957-06-04 | 1959-07-28 | Upjohn Co | Pharmaceutical composition |
US3119738A (en) * | 1962-04-12 | 1964-01-28 | Wisconsin Alumni Res Found | Medication for ruminants |
US3594470A (en) * | 1968-02-19 | 1971-07-20 | Abbott Lab | Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin |
FR2183546B1 (de) * | 1972-05-10 | 1975-06-20 | Servier Lab | |
US4011061A (en) * | 1975-03-20 | 1977-03-08 | Minnesota Mining And Manufacturing Company | Articles providing sustained release and method of making |
US4284444A (en) * | 1977-08-01 | 1981-08-18 | Herculite Protective Fabrics Corporation | Activated polymer materials and process for making same |
CA1125698A (en) * | 1978-03-09 | 1982-06-15 | Masaru Yoshida | Process for preparing a polymer composition |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
US4308251A (en) * | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
IT1176853B (it) * | 1984-10-02 | 1987-08-18 | Eurand Spa | Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua |
US4600645A (en) * | 1985-01-31 | 1986-07-15 | Warner-Lambert Company | Process for treating dosage forms |
-
1986
- 1986-06-17 US US06/875,146 patent/US4810501A/en not_active Expired - Fee Related
-
1987
- 1987-05-27 ZA ZA873851A patent/ZA873851B/xx unknown
- 1987-06-12 AU AU74196/87A patent/AU611085B2/en not_active Ceased
- 1987-06-13 KR KR1019870005994A patent/KR950003609B1/ko active IP Right Grant
- 1987-06-15 FI FI872652A patent/FI872652A/fi not_active IP Right Cessation
- 1987-06-15 PH PH35410A patent/PH24152A/en unknown
- 1987-06-16 NZ NZ220722A patent/NZ220722A/xx unknown
- 1987-06-16 DE DE8787108670T patent/DE3783163T2/de not_active Expired - Fee Related
- 1987-06-16 EP EP87108670A patent/EP0249949B1/de not_active Expired - Lifetime
- 1987-06-16 AT AT87108670T patent/ATE83649T1/de not_active IP Right Cessation
- 1987-06-16 JP JP62148160A patent/JPS63258406A/ja active Pending
- 1987-06-16 DK DK305287A patent/DK305287A/da not_active Application Discontinuation
- 1987-06-16 NO NO872499A patent/NO872499L/no unknown
- 1987-06-16 ES ES87108670T patent/ES2053470T3/es not_active Expired - Lifetime
- 1987-06-17 PT PT85105A patent/PT85105B/pt unknown
- 1987-06-17 CA CA000539906A patent/CA1297016C/en not_active Expired - Fee Related
-
1993
- 1993-02-04 GR GR930400231T patent/GR3006981T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK305287A (da) | 1987-12-18 |
AU611085B2 (en) | 1991-06-06 |
PH24152A (en) | 1990-03-22 |
NZ220722A (en) | 1990-06-26 |
CA1297016C (en) | 1992-03-10 |
FI872652A0 (fi) | 1987-06-15 |
EP0249949A2 (de) | 1987-12-23 |
EP0249949B1 (de) | 1992-12-23 |
NO872499D0 (no) | 1987-06-16 |
JPS63258406A (ja) | 1988-10-25 |
KR950003609B1 (ko) | 1995-04-17 |
KR880000106A (ko) | 1988-03-23 |
AU7419687A (en) | 1987-12-24 |
EP0249949A3 (en) | 1988-03-16 |
PT85105B (pt) | 1990-03-08 |
DE3783163D1 (de) | 1993-02-04 |
ES2053470T3 (es) | 1994-08-01 |
ZA873851B (en) | 1987-11-25 |
DK305287D0 (da) | 1987-06-16 |
PT85105A (en) | 1987-07-01 |
GR3006981T3 (de) | 1993-06-30 |
DE3783163T2 (de) | 1993-04-22 |
US4810501A (en) | 1989-03-07 |
FI872652A (fi) | 1987-12-18 |
NO872499L (no) | 1987-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE83649T1 (de) | Arzneimittelzubereitungen mit verzoegerter freisetzung. | |
ATE252900T1 (de) | Pharmazeutische granulate mit intragranularem sprengmittel | |
DK0560092T3 (da) | Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer | |
DE3778106D1 (de) | Dosierungsform mit verzoegernder freisetzung. | |
NL194031B (nl) | Farmaceutische samenstelling met analgetische werking. Farmaceutische samenstelling met een analgetische werking en daaruit met geschikte excipiÙntia gevormd granulaat. | |
FI943327A0 (fi) | Parannetun kestävyyden omaavien tablettien valmistus | |
DK32590D0 (da) | Presse til fremstilling af tabletter med overtraek | |
FI954232A (fi) | Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa | |
FR2604341B1 (fr) | Agglomerats de granules de pommes de terre | |
ATE69547T1 (de) | Formlinge aus pellets. | |
EP0347748A3 (en) | Pharmaceutical granules and tablets made therefrom | |
DE3152182A1 (de) | Polymere diffusionsmatrix zur verabreichung von medikamenten | |
JPS57130913A (en) | Direct compress analgesic drug granulating composition, tablets thereof and manufacture | |
BR8407246A (pt) | Polimeros de organossiloxano e composicoes contendo os mesmos,curaveis pela exposicao a oxigenio gasoso | |
DE3681856D1 (de) | Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung. | |
DE68909555D1 (de) | Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung. | |
ATE64814T1 (de) | Kombinations-traegergranulate. | |
DE3787580D1 (de) | Lichtempfindliches material mit silberhalogenid, reduktionsmittel und photopolymerisierbare verbindungen. | |
ATE82497T1 (de) | Pharmazeutische granula und daraus hergestellte tabletten. | |
TR26944A (tr) | Melamim toz tabaka ile techiz edilmis üre tanelenmesi. | |
ATE19459T1 (de) | Verwendung von beta-sulphonylacrylsaeurederivaten, diese enthaltende trockene mischungen und daraus hergestellte granulate in synthetischen polymeren. | |
ATE23018T1 (de) | Traeger mit staendiger abgabe von trinitroglycerin, sowie zusammensetzungen dazu. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |